Skip to Content

Erymax 250mg (Erythromycin delayed-release 250 mg)

Pill imprint Erymax 250mg has been identified as Erythromycin delayed-release 250 mg.

Erythromycin is used in the treatment of dental abscess; upper respiratory tract infection; skin or soft tissue infection; bronchitis; strep throat (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Erythromycin delayed-release 250 mg Erymax 250mg
Discount Card Promo
Erythromycin delayed-release
Erymax 250mg
250 mg
Orange / Clear
Prescription only
Drug Class:
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Midlothian Laboratories

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.